All Clinical Tools
Clinical decision support

Renal dose adjuster

Automatic dose adjustment is unavailable. CKD stage alone does not establish a safe drug dose or interval. Review a creatinine range below, then use current drug-specific references and patient assessment for dosing.

Uses the IRIS table in the selected laboratory unit, without rounding your input. Values between published ranges require review. Unit equivalents are approximate (1 mg/dL = 88.4 µmol/L); the published cutoffs are rounded and do not convert exactly.

Creatinine reference only: this does not diagnose CKD or assign a final IRIS stage. Do not apply CKD staging to suspected acute kidney injury, dehydration or an unstable patient. Interpret creatinine with SDMA, muscle mass, breed/size and serial trends; substage by renal proteinuria (UP/C) and blood pressure.

Educational support only. Verify with clinical judgment and current references.
Safety checks
  • This tool supports calculation and education only.
  • It does not diagnose, prescribe, or replace clinical judgment.
  • CKD stage is not a measured GFR or a universal drug-clearance factor.
  • No automatic dosing, interval selection, or drug-class recommendation is provided.
  • Always consult current formulary and pharmacology references.
Basis and limits
  • IRIS 2026, dogs: Stage 1 <1.4; Stage 2 1.4–2.8; Stage 3 2.9–5.0; Stage 4 >5.0 mg/dL.
  • IRIS 2026, cats: Stage 1 <1.6; Stage 2 1.6–2.8; Stage 3 2.9–5.0; Stage 4 >5.0 mg/dL.
  • µmol/L, dogs: Stage 1 <125; Stage 2 125–250; Stage 3 251–440; Stage 4 >440.
  • µmol/L, cats: Stage 1 <140; Stage 2 140–250; Stage 3 251–440; Stage 4 >440.
  • Precision: a value between 2.8 and 2.9 mg/dL or between 250 and 251 µmol/L is flagged for review rather than silently rounded. Near a cutoff, confirm laboratory reporting precision and interpret serial creatinine and SDMA together.
  • SDMA: persistent discordance may change the stage and treatment category. The IRIS SDMA recommendations use the IDEXX assay; equivalent results from other assays are not established.
  • Low creatinine: a Stage 1 creatinine range alone does not establish CKD. Other evidence of renal abnormality is needed.
Reference audit trail

Reference details will appear here after review.

Last reviewed: IRIS 2026 source checked. Owner-approved: 16 October 2026. Next review: by 16 October 2027, or sooner if guidance changes. Owner approval is not external veterinary clinical sign-off.

References: IRIS Staging of CKD (Modified 2026), pages 1–4; IRIS guidelines and treatment recommendations (2026). These sources support staging and individualized assessment, not universal dose multipliers. Consult a current drug-specific formulary for prescribing. Report a clinical concern.